Old Web
English
Sign In
Acemap
>
authorDetail
>
Jennifer Bartsch
Jennifer Bartsch
RTI International
Darolutamide
Quality of life
Internal medicine
Medicine
Castrate-resistant prostate cancer
2
Papers
15
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial.
2021
European Journal of Cancer
Matthew R. Smith
Neal D. Shore
Teuvo L.J. Tammela
Albertas Ulys
Egils Vjaters
Sergey Polyakov
Mindaugas Jievaltas
Murilo Luz
Boris Alekseev
Iris Kuss
Marie-Aude Le Berre
Ateesha F. Mohamed
Dawn Odom
Jennifer Bartsch
Amir Snapir
Toni Sarapohja
Karim Fizazi
Show All
Source
Cite
Save
Citations (1)
Impact of darolutamide (DARO) on pain and quality of life (QoL) in patients (Pts) with nonmetastatic castrate-resistant prostate cancer (nmCRPC).
2019
Journal of Clinical Oncology
Karim Fizazi
Neal D. Shore
Teuvo L.J. Tammela
Iris Kuss
Marie-Aude Le Berre
Ateesha F. Mohamed
Dawn Odom
Jennifer Bartsch
Amir Snapir
Toni Sarapohja
Matthew R. Smith
Show All
Source
Cite
Save
Citations (14)
1